Reliance GeneMedix PLC GMX

Last Price
-

Day Change
-|-%

As of -
| GBP Minimum 15 Minutes Delay.

Bid/Offer	Day Range	Volume	90d Ave Vol	Mkt Cap
- - -	-	-	-	1.048 Mil

Last Close	52 Week Range	P/E	Yield %	ISIN
-	-	-	-	GB00B1MM9925

Reliance GeneMedix Share Price

more...

Financials
	Annual
	2010	2011	2012
more...
Income Statement
Revenue	0	1	1
Operating Income	-2	-2	-2
Net Income	-2	-3	-2
Basic EPS	-0.01	-0.01	-0.01
Avg. Diluted Shares Outstanding	164	190	190
Balance Sheet
Current Assets	1	1	1
Non Current Assets	18	20	21
Total Assets	19	21	21
Current Liabilities	3	6	2
Total Liabilities	9	14	16
Shareholder Equity	10	7	5
Cash Flow
Cash From Operations	-1	-2	-1
Capital Expenditure	-4	-3	-1
Free Cash Flow	-6	-5	-3

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Reliance GeneMedix PLC operates as a biopharmaceutical company which is engaged in the development and manufacture of high-quality, cost-effective treatments for some of the world's most serious diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

March

Employees

Key Stats
more...
Price/Earning TTM	-
Price/Book	-
Price/Sales TTM	-
Rev Growth (3 year avg)	0.36
EPS Growth (3 year avg)	-
Operating Margin % TTM	-343.08
Net Margin % TTM	-353.61
ROE TTM	-35.18
Debt/Equity	4.22

Welcome to Morningstar.co.uk!

For more information: